FREGA, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.116
EU - Europa 152
AS - Asia 55
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.324
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.115
IT - Italia 46
CN - Cina 32
SE - Svezia 29
FI - Finlandia 27
GB - Regno Unito 18
DE - Germania 14
VN - Vietnam 14
BE - Belgio 11
TW - Taiwan 4
IN - India 3
TR - Turchia 2
UA - Ucraina 2
CA - Canada 1
CH - Svizzera 1
ES - Italia 1
EU - Europa 1
FR - Francia 1
IE - Irlanda 1
NL - Olanda 1
Totale 1.324
Salva come PNG Salva come JPEG
Città #
Fairfield 204
Woodbridge 134
Chandler 125
Cambridge 92
Ashburn 80
Houston 79
Seattle 73
Wilmington 70
Ann Arbor 38
San Diego 25
Helsinki 22
Medford 18
Padova 18
Princeton 18
Dong Ket 14
Beijing 12
Des Moines 12
Brussels 11
Roxbury 11
Columbus 8
Nanjing 7
Washington 6
Boardman 4
Dearborn 4
Hsinchu County 4
London 4
Tianjin 4
Ningbo 3
Avezzano 2
Belluno 2
Duncan 2
Hanover 2
Jinan 2
Milan 2
Milazzo 2
Pignone 2
Portland 2
Amsterdam 1
Ankara 1
Bellaterra 1
Chiswick 1
Dublin 1
Haikou 1
Hangzhou 1
Jolanda di Savoia 1
Lappeenranta 1
Leawood 1
New York 1
Norwalk 1
Nutley 1
Orange 1
Palermo 1
Redmond 1
Rome 1
Taizhou 1
Toronto 1
Zonguldak 1
Totale 1.138
Salva come PNG Salva come JPEG
Nome #
A triple rare E709K and L833V/H835L EGFR mutation responsive to an irreversible pan-HER inhibitor: A case report of lung adenocarcinoma treated with afatinib 148
166P: Non-small cell lung cancer (NSCLC) patients with rare or complex epidermal growth factor receptor (EGFR) mutations: A single institution series 138
From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study) 126
Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature 114
Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations 111
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy 71
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome 67
Squamous cell carcinomas of the lung and of the head and neck: New insights on molecular characterization 66
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy 64
Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future? 60
1398P Real-life progression (PD) pattern of EGFR mutant advanced non-small cell lung cancer (aNSCLC) patients (pts) receiving systemic therapy after first- or second-generation tyrosine kinase inhibitor (1-2 gen TKI) 58
149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW) 58
Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC 53
119P The role of circulating markers in predicting immune-related adverse events (irAEs) and their recurrence in advanced non-small cell lung cancer (aNSCLC) patients (pts) 50
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines 49
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 47
Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome 40
Detection of loss of heterozygosity in cfDNA of advanced EGFR-or KRAS-mutated non-small-cell lung cancer patients 33
Totale 1.353
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.759
article - articoli 3.759
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.518
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201990 0 0 0 0 1 0 2 9 1 17 32 28
2019/2020291 21 13 4 78 29 18 18 28 32 18 28 4
2020/2021210 14 9 18 4 6 17 33 16 30 15 10 38
2021/2022371 17 45 40 16 26 43 49 21 13 10 30 61
2022/2023251 39 39 7 32 26 20 2 16 40 8 20 2
2023/202472 15 21 36 0 0 0 0 0 0 0 0 0
Totale 1.353